Login / Signup
FcγRIIb blockage: a promising immunotherapy target for severe COVID-19.
Xuemei He
Manni Wang
Mingshan Jiang
Published in:
Signal transduction and targeted therapy (2021)
Keyphrases
</>
coronavirus disease
sars cov
early onset
respiratory syndrome coronavirus